The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBoston Int Regulatory News (BIH)

  • This share is currently suspended. It was suspended at a price of 0.598

Share Price Information for Boston Int (BIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.598
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.598
BIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 Sep 2023 07:00

RNS Number : 7518N
Boston International Holdings PLC
27 September 2023
 

BOSTON INTERNATIONAL HOLDINGS PLC

("BIH" or "the Company")

 

27 September 2023

 

 

UNAUDITED HALF YEAR REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2023

 

 

Boston International Holdings plc, formed in November 2015, which operates as a special purpose acquisitions company (SPAC) to undertake one or more acquisitions of target companies or businesses, announces its unaudited half year report for the six months ended 30 June 2023.

 

Chairman's Statement

 

I have pleasure in presenting the interim results of Boston International Holdings Plc for the six months ended 30 June 2023.

 

During the financial period under review, the Company reported a net loss of £195,940, being the administrative expenses incurred. As at 30 June 2023 the Company had cash reserves £45,725.

 

During the period under review the Directors have continued to actively review potential acquisition opportunities for the Company and on 27 April 2023 announced that the Company is in preliminary discussions with the shareholders of Topic S.A. ("Topic") for the acquisition of all (or, at least, not less than a majority) of the issued share capital of Topic in exchange for the issue of new ordinary shares in the Company (the "Potential Acquisition").

 

The evaluation and due diligence on the Potential Acquisition is ongoing and the Company will update the Shareholders further in due course.

 

It should be noted though that following the changes to the Financial Conduct Authority's (the "FCA") Listing Rules announced on 2 December 2021, which confirmed an increase to the minimum market capitalisation threshold for both the premium and standard listing segments for shares in ordinary commercial companies from £700,000 to £30 million, the Company, as a standard listed SPAC that listed before 3 December 2021, is subject to transitional provisions in relation to market capitalisation which allows it to rely on the £700,000 market capitalisation. This transitional provision comes to an end later this year and therefore to be able to utilise it, the Company will need to make a complete submission to the FCA in relation to a reverse takeover transaction by 4.00pm on 1 December 2023. Should the Company not be able to make a complete submission within this period, it will no longer be able to rely on the transitional provision and will need comply with £30 million market capitalisation requirement.

 

Christopher Pitman

Chairman

 

 

Interim Management Report

 

Company Objective

 

The Company was originally formed to undertake an acquisition of a target company or business in the foreign exchange (FX) sector, however due to a lack of current opportunities in that sector, following the general meeting held on 6 September 2019, the Directors' efforts in identifying a prospective target company or business are no longer limited to a particular industry or geographic region.

 

Following completion of an acquisition, the objective of the Company will be to operate the acquired business and implement an operating strategy with a view to generating value for its shareholders through operational improvements as well as potentially through additional complementary acquisitions following the acquisition.

 

Key Events

 

On 27 January 2023, the Company announced that the Directors have subscribed for an aggregate of 16,000,000 new ordinary shares of 0.1 pence each at a subscription price of 0.5 pence per share in cash, raising £80,000 for the Company.

 

On 27 April 2023, the Company announced that it is in preliminary discussions with the shareholders of Topic for the acquisition of all (or, at least, not less than a majority) of the issued share capital of Topic in exchange for the issue of new ordinary shares in the Company. Topic is a privately-owned, oil and gas exploration and production company, incorporated in Tunisia, with interests in three oil and gas blocks in offshore and onshore Tunisia. If completed it would result in the Company's existing shareholders having a minority interest in the enlarged group and would constitute a reverse takeover under the FCA's Listing Rules. The Company's issued ordinary shares have therefore been suspended from the FCA's Official List (standard segment). The Potential Acquisition remains subject to satisfactory completion of customary due diligence, regulatory and shareholder approvals.

 

On 26 June 2023, the Company announced that Boston Merchant (HK) Limited, a company controlled by Mr. James, a Director of the Company, had subscribed for 20,000,000 new ordinary shares of 0.1 pence at a subscription price of 0.5 pence per share in cash. The funds, amounting to £100,000, will be used for on-going working capital purposes.

 

Principal Risks and Uncertainties

 

The Company is subject to a number of risk factors. The Directors have identified the following key risks in the second six months of this financial year. Other risk factors not presently known or currently deemed immaterial may also apply.

· The Company is dependent on its directors, in particular the Chairman, to manage the Company and its future strategy. If the Company were to lose the services of the Chairman, it could have a material adverse effect on the Company and its ability to implement its future strategy.

· The Company is a standard listed SPAC that listed before 3 December 2021. As such, following the changes to the Listing Rules announced on 2 December 2021 which confirmed an increase to the minimum market capitalisation threshold for both the premium and standard listing segments for shares in ordinary commercial companies from £700,000 to £30 million, the Company is subject to transitional provisions in relation to market capitalisation which allows it to rely on the £700,000 market capitalisation. This transitional provision comes to an end later this year and therefore to be able to utilise it, the Company will need to make a complete submission to the FCA in relation to a reverse takeover transaction by 4.00pm on 1 December 2023. Should the Company not be able to make the submission within this period, it will no longer be able to rely on the transitional provision and will need to comply with £30 million market capitalisation requirement.

· The Company is a SPAC whose main aim is to acquire an operating business. There is an inherent risk in evaluation of any potential acquisition target and although the Company and the Directors will evaluate risks pertaining to a particular target, there can be no certainty that all of the significant risks can be identified or properly assessed.

The Company intends to finance any acquisition through the issue of Ordinary Shares however it may be the case that any such acquisition may be only partially funded by equity and the Company may need to raise substantial additional capital to fund any acquisition. Whilst the Company continues its assessment of the Potential Acquisition it remains open to other potential acquisition opportunities and the Board will continue to prudently manage the Company's remaining cash reserves and minimise its operating expenses in order to put the Company in the best position possible to complete an acquisition.

Responsibility Statement

 

The Directors are responsible for preparing the Interim Report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority ("DTR") and with International Accounting Standard 34 on Interim Financial Reporting (IAS 34).

 

The Directors (all non-executive) being Christopher Pitman, Martin Lampshire, W Borden James and Richard Hartheimer confirm that to the best of their knowledge:

 

· the interim financial statements, prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company; and

 

· the interim financial statements have been prepared in accordance with IAS 34 and that as required by DTR 4.2.7 and DTR 4.2.8, the Interim Report gives a fair review of:

- important events that have occurred during the first six months of the year;

- the impact of those events on the financial statements;

- a description of the principal risks and uncertainties for the remaining six months of the financial year; 

- details of any related party transactions that have materially affected the Company's financial position or performance in the six months ended 30 June 2023; and

- any changes in the related parties transactions described in the last annual report that could have a material effect on the financial position or performance of the enterprise in the first six months of the current financial year.

 

By order of the Board

 

 

Christopher Pitman

Chairman

 

26 September 2023

 

 

 

Boston International Holdings plc

Condensed Statement of Comprehensive Income

 

Six months

Six months

12 months

30 June

30 June

31 December

2023

2022

2022

Note

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Revenue

 

-

-

-

Administrative expenses

(196)

(279)

(418)

Operating loss

 

(196)

(279)

(418)

Finance income/(expense)

-

10

(16)

Loss on ordinary activities before taxation

 

(196)

(269)

(434)

Income tax expense

-

-

-

Loss after taxation

 

(196)

(269)

(434)

Other comprehensive income

 

-

-

-

Total comprehensive income attributable to

 

(196)

(269)

(434)

owners of the parent

 

Earnings per share (EPS):

 

Basic and diluted(pence)

 

3

(0.15)

(0.32)

(0.84)

 

 

Boston International Holdings plc

Condensed Statement of Financial Position as at 30 June 2023

 

6 months

6 months

12 months

30 June

30 June

31 December

2023

2022

2022

Note

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Current assets

 

Other receivables and prepayments

15

19

28

Cash and bank balances

46

182

50

Total Assets

 

61

201

78

Current Liabilities

 

Convertible Loan Notes

(214)

-

(214)

Other payables and accruals

(165)

(83)

(166)

Total current liabilities

(379)

(83)

(380)

Liabilities due in more than 12 months

 

Convertible Loan Notes

-

(203)

-

Total liabilities due in more than 12 months

 

-

(203)

-

Total Liabilities

 

(379)

(286)

(380)

Net Liabilities

 

(318)

(85)

(302)

Equity

 

Share capital

4

148

1,122

112

Share premium

1,462

1,318

1,318

Other reserves

34

35

34

Reserves

(1,962)

(2,560)

(1,766)

Total Equity

(318)

(85)

(302)

Boston International Holdings plc

Condensed Statement of Changes in Equity

For the six month period ended 30 June 2023 (Unaudited)

 

Share

Share

Other

Retained

Total

capital

premium

reserves

profits

equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 January 2022

639

1,318

40

(2,291)

(294)

Issue of shares

483

-

-

-

483

Loss for the period

-

-

-

(269)

(269)

Convertible Loan Notes-

equity element

-

-

(5)

-

(5)

Balance at 30 June 2022

1,122

1,318

35

(2,560)

(85)

Loss for the period

-

-

-

(216)

(216)

Convertible Loan Notes-

equity element

-

-

(1)

-

(1)

Cancellation of deferred shares

(1,010)

-

-

1,010

-

Balance at 31 December 2022

112

1,318

34

(1,766)

(302)

Issue of shares

36

144

-

-

180

Loss for the period

-

-

-

(196)

(196)

Balance at 30 June 2023

148

1,462

34

(1,962)

(318)

 

 

 

 

 

 

Boston International Holdings plc

Condensed Statements of Cash Flows

For the six-month period ended 30 June 2023

 

6 months

6 months

12 months

30 June

30 June

31 December

2023

2022

2022

Note

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flow from operating activities

 

Loss before taxation

(196)

(269)

(484)

Adjustment for:

 

Interest income/(expense)

-

(10)

-

Operating cash flows before movements in working capital

(196)

(279)

(484)

Decease/(increase) in trade and other receivables

 

13

12

3

Decrease/(increase) in trade and other payables

(1)

49

131

Cash generated from operations

12

61

134

Cash flows from operating activities

 

(184)

(218)

(350)

Proceeds from share issue

180

483

187

Convertible Loan Notes

-

(158)

148

Net cash generated from financing activities

180

325

335

Cash flows from investing activities

 

Interest received/(expenses)

-

10

-

Net cash generated from investing activities

-

-

-

Net Increase/(decrease) in cash & cash equivalents

(4)

117

(15)

Cash and equivalent at beginning of the period

50

65

65

Cash and equivalent at end of the period

 

46

182

50

 

 

Boston International Holdings plc

NOTES TO THE FINANCIAL INFORMATION

 

1. GENERAL INFORMATION AND PRINCIPAL ACTIVITIES

 

The Company is incorporated in England and Wales as a public limited company with company number 09876705. The registered office of the Company is Holborn Gate, 330 High Holborn, London WC1V 7QT.

 

This financial information is for the Company only as there are no subsidiary undertakings.

 

The principal place of business of the Company is in the United Kingdom.

 

The interim financial statements are presented in the nearest thousands of Pounds Sterling (£'000), which is the presentation currency of the company.

 

 

2. BASIS OF PREPARATION

 

The interim financial statements for the six months ended 30 June 2023 have been prepared in accordance with IAS 34, Interim Financial Reporting.

 

The principal accounting policies used in preparing the interim results are the same as those applied in the Company's Financial Statements as at and for the period ended 31 December 2022.

 

A copy of the audited financial statements for the period ended 31 December 2022, which was prepared under IFRS, is available on the Company's website.

 

The interim report for the six months ended 30 June 2023 was approved by the Directors on 26 September 2023.

 

 

3. EARNINGS PER SHARE

 

The earnings per share information is as follows:

 

 

Six months

Six months

12 months

30 June

30 June

31 December

2023

2022

2022

Unaudited

Unaudited

Audited

(Loss) after taxation (Pound £)

(195,940)

(268,877)

(484, 944)

Weighted average number of ordinary shares

126,805,579

82, 614,914

97,539,045

Basic earnings per share (pence)

(0.15)

(0.32)

(0.50)

The diluted earnings per share was not applicable as there were no dilutive potential ordinary shares outstanding at the end of the reporting period. IAS33 requires presentation of diluted EPS when a company could be called upon to issue shares that decrease earnings per share or increase the loss per share. For a loss-making company with outstanding share options or warrants, net loss per share would be decreased by exercise of options. Therefore, per IAS33.36 the antidilutive potential ordinary shares are disregarded in the calculation of diluted EPS.

 

 

 

 

4. Share Capital

Issued, called up and fully paid Ordinary shares of £0.001 each.

 

Number

of shares

 

£'000

 

As at 1 January 2023

112,219,943

112

Issue of shares

 

36,000,000

36

As at 30 June 2023

148,219,943

148

 

 

 

 

 

5. RELATED PARTY TRANSACTIONS

 

Key management are considered to be the directors and the key management received no compensation in the period.

 

On 27 January 2023, the Company announced that the Directors have subscribed for an aggregate of 16,000,000 new ordinary shares of 0.1 pence each in the Company at a subscription price of 0.5 pence per share in cash, raising £80,000 for the Company.

 

On 23 June 2023, Boston Merchant (HK) Limited, which is a company controlled by Mr James, a Director of the Company, subscribed for 20, 000,000 new ordinary shares of 0.1 pence each in the Company, at a subscription price of 0.5 pence per share in cash.

 

6. SEASONAL OR CYCLICAL FACTORS

 

There are no seasonal factors that materially affect the operations of the company.

 

7. EVENTS AFTER THE REPORTING DATE

 

There are no reportable events.

- ENDS -

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR").

For further information, please contact:

 

Boston International Holdings Plc

Christopher Pitman, Chairman +44 (0) 20 3735 8825

 

Peterhouse Capital Limited (Broker)

Lucy Williams / Duncan Vasey +44 (0) 20 7469 0930

 

Beaumont Cornish Limited (Financial Adviser)

Roland Cornish/Asia Szusciak +44 (0) 20 7628 3396

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDCSDDDGXL
Date   Source Headline
3rd Jan 202411:08 amRNSAcquisition Update & New Convertible Loan Notes
5th Oct 20237:00 amRNSHeads of Terms Signed re Potential Acquisition
29th Sep 20237:00 amRNSConvertible Loan Notes Repayment Date Extended
27th Sep 20237:00 amRNSHalf-year Report
26th Jun 202311:40 amRNSIssue of Ordinary Shares to Boston Merchant (HK)
20th Jun 20231:01 pmRNSAnnual Report and Accounts – Replacement
20th Jun 20237:00 amRNSFinal Results
28th Apr 20234:30 pmRNSAnnual Report - Delay in Publication
27th Apr 20235:24 pmRNSPotential RTO of Topic S.A & Suspension of Listing
27th Mar 202312:43 pmRNSAppointment of Auditor
9th Feb 20233:51 pmRNSHolding(s) in Company
7th Feb 20237:30 amRNSHolding(s) in Company
31st Jan 20231:38 pmRNSHolding(s) in Company
31st Jan 20231:37 pmRNSHolding(s) in Company
31st Jan 20231:25 pmRNSHolding(s) in Company
31st Jan 20231:14 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectors' Subscriptions for New Ordinary Shares
23rd Dec 202210:44 amRNSHolding(s) in Company
9th Dec 20222:52 pmRNSResult of 2022 AGM
1st Dec 20226:10 pmRNSTotal Voting Rights
17th Nov 20227:30 amRNSAnnouncement of AGM and PDMR Dealings
11th Nov 202211:30 amRNSHolding(s) in Company
21st Oct 202210:21 amRNSHolding(s) in Company
19th Oct 20223:42 pmRNSHolding(s) in Company
18th Oct 20221:30 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSHalf-year Report
3rd Aug 20222:25 pmRNSHolding(s) in Company
30th Jun 20222:20 pmRNSAnnual Financial Report
25th May 202210:09 amRNSHolding(s) in Company
20th May 20223:45 pmRNSResult of General Meeting
5th May 20229:00 amRNSDirector/PDMR Shareholding
3rd May 202212:36 pmRNSHolding(s) in Company
29th Apr 20225:22 pmRNSTotal Voting Rights
29th Apr 202211:14 amRNSHolding(s) in Company
29th Apr 202210:15 amRNSHolding(s) in Company
29th Apr 202210:14 amRNSHolding(s) in Company
29th Apr 202210:13 amRNSHolding(s) in Company
27th Apr 20225:50 pmRNSPosting of Circular, GM Notice & Issue of New CLN
22nd Apr 20221:46 pmRNSFundraising & Issue of New Convertible Loan Notes
20th Apr 20223:00 pmRNSHolding(s) in Company
12th Apr 202212:20 pmRNSVariation and Partial Conversion of Existing CLN
7th Mar 20227:00 amRNSConvertible Loan Note Repayment Date Extended
31st Jan 20222:46 pmRNSResult of AGM
17th Jan 20222:11 pmRNSAdjournment of Annual General Meeting
7th Jan 20225:57 pmRNSHolding(s) in Company
20th Dec 20217:00 amRNSPosting of Notice of AGM & 2020 Report & Accounts
30th Sep 20217:00 amRNSHalf-year Report
30th Jul 20216:19 pmRNSHolding(s) in Company
30th Jul 202111:50 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.